ロード中...
Hospitalizations within 14 days of vaccination among pediatric recipients of the live attenuated influenza vaccine, United States 2010–2012
BACKGROUND: Live attenuated influenza vaccine (LAIV) is safe in healthy children ⩾2 years. The original clinical trials excluded individuals with underlying conditions; however, post-marketing data suggest LAIV may be safe for these populations. METHODS: We analyzed MarketScan Commercial Claims Data...
保存先:
| 出版年: | Vaccine |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5949885/ https://ncbi.nlm.nih.gov/pubmed/28041779 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2016.12.033 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|